- Home
- RZLT vs STRO Comparison
RZLT vs STRO Comparison
Compare RZLT & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RZLT
- STRO
- Stock Information
- Founded
- RZLT 2010
- STRO 2003
- Country
- RZLT United States
- STRO United States
- Employees
- RZLT N/A
- STRO N/A
- Industry
- RZLT Biotechnology: Pharmaceutical Preparations
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RZLT Health Care
- STRO Health Care
- Exchange
- RZLT Nasdaq
- STRO Nasdaq
- Market Cap
- RZLT 819.3M
- STRO 94.9M
- IPO Year
- RZLT N/A
- STRO 2018
- Fundamental
- Price
- RZLT $9.10
- STRO $1.10
- Analyst Decision
- RZLT Strong Buy
- STRO Hold
- Analyst Count
- RZLT 7
- STRO 7
- Target Price
- RZLT $14.86
- STRO $1.97
- AVG Volume (30 Days)
- RZLT 1.4M
- STRO 1.6M
- Earning Date
- RZLT 11-07-2025
- STRO 11-10-2025
- Dividend Yield
- RZLT N/A
- STRO N/A
- EPS Growth
- RZLT N/A
- STRO N/A
- EPS
- RZLT N/A
- STRO N/A
- Revenue
- RZLT N/A
- STRO $104,473,000.00
- Revenue This Year
- RZLT N/A
- STRO $65.48
- Revenue Next Year
- RZLT N/A
- STRO N/A
- P/E Ratio
- RZLT N/A
- STRO N/A
- Revenue Growth
- RZLT N/A
- STRO N/A
- 52 Week Low
- RZLT $2.22
- STRO $0.52
- 52 Week High
- RZLT $10.04
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- RZLT 52.01
- STRO 56.81
- Support Level
- RZLT $9.00
- STRO $1.02
- Resistance Level
- RZLT $10.03
- STRO $1.20
- Average True Range (ATR)
- RZLT 0.57
- STRO 0.13
- MACD
- RZLT -0.03
- STRO 0.01
- Stochastic Oscillator
- RZLT 40.56
- STRO 61.06
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.